Statistics for Targeting Ref-1/APE1 Pathway Inhibition in Pancreatic Cancer Using APX3330 for Clinical Trials

Total visits

views
Targeting Ref-1/APE1 Pathway Inhibition in Pancreatic Cancer Using APX3330 for Clinical Trials 322

Total visits per month

views
January 2024 0
February 2024 1
March 2024 0
April 2024 0
May 2024 0
June 2024 0
July 2024 0

File Visits

views
Shah.pdf 109

Top country views

views
United States 223
Germany 27
United Kingdom 7
Sweden 6
Ukraine 6
Russia 4
China 3
India 3
France 2
Italy 2
Australia 1
Canada 1
Switzerland 1
Malaysia 1
Pakistan 1
Poland 1
Turkey 1
Taiwan 1
Uzbekistan 1

Top city views

views
Wilmington 64
Ann Arbor 39
Kiez 19
Lake Mary 10
Washington 9
Indianapolis 8
White Plains 8
Fairfield 6
Jacksonville 6
Kiev 6
Houston 4
San Francisco 4
Stockholm 4
Baltimore 3
Dearborn 3
Gunzenhausen 3
Kansas City 3
Saint Petersburg 3
Tacoma 3
Boston 2
Bronx 2
Brooklyn 2
Concord 2
Düsseldorf 2
Largo 2
Loughborough 2
Mount Laurel 2
Mumbai 2
Paris 2
Shrewsbury 2
Adiyaman 1
Alexandria 1
Ama 1
Basildon 1
Berlin 1
Biel 1
Birmingham 1
Bloomington 1
Brisbane 1
Cambridge 1
Chicago 1
Duncan 1
East Lansing 1
Gdansk 1
Gilbert 1
Gothenburg 1
Grùmolo 1
Hefei 1
Irvine 1
Islamabad 1
Kalmar 1
La Jolla 1
Louisburg 1
Ludwigshafen 1
Milan 1
Mountain View 1
Nashville 1
New Albany 1
Nürnberg 1
Philadelphia 1
Plymouth Meeting 1
Rancho Santa Margarita 1
Sacramento 1
Seremban 1
Taipei 1
Tashkent 1
Toronto 1
Tula 1
Tustin 1
University 1
Waltham 1
Warrington 1
Whiteland 1
Xian 1